RNASEL and prostate carcinoma: In fact, some mutations in the tumor-suppressor gene RNASEL have been found to lead to ribonuclease L dysfunction, inflammation, infection, and increased risk of prostate cancer, suggesting links between innate immunity and tumor suppression [51].